CorMedix, Inc. (CRMD):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:CorMedix, Inc. (CRMD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137874FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

CorMedix Inc. (CorMedix) is a specialty pharmaceutical company. It develops and commercializes products for prevention and treatment of renal, cardiac, metabolic and infectious diseases. CorMedix enables targeted therapy through its therapeutic candidates such as small molecules, chemical entities, biologics, and devices, among others. Its foundational technology focuses on prevention of infection and clotting caused by the use of chronic central venous catheters (CVCs) in hemodialysis (HD) patients receiving chronic antibiotic therapy, chemotherapy, and intensive care. The company’s licensed products include CRMD003 (Neutrolin), a catheter lock solution that not only prevents of Catheter Related Bloodstream Infections but also maintains catheter patency and CRMD004, a thixotropic gel, in pre-clinical development. CorMedix commercializes its products globally either by out-licensing, partnering, or through its sales force. The company operates in Europe through its subsidiary, CorMedix Europe GmbH, in the area of dialysis services. CorMedix is headquartered in Bridgewater, New Jersey, the US.

CorMedix, Inc. Key Recent Developments

Nov 15, 2013: CorMedix to report third quarter financial results on November 19, 2013
Oct 23, 2013: CorMedix Inc. closes $3,000,000 preferred stock offerings
Oct 18, 2013: CorMedix Inc. to raise $3,000,000 in concurrent offerings
Sep 05, 2013: CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union
Aug 15, 2013: CorMedix Appoints Steven Lefkowitz As Interim CFO

This comprehensive SWOT profile of CorMedix, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of CorMedix, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

CorMedix, Inc. – Key Information
CorMedix, Inc. – Overview
CorMedix, Inc. – Key Employees
CorMedix, Inc. – Key Employee Biographies
CorMedix, Inc. – Key Operational Heads
CorMedix, Inc. – Major Products and Services
CorMedix, Inc. – History
CorMedix, Inc. – Company Statement
CorMedix, Inc. – Locations And Subsidiaries
CorMedix, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

CorMedix, Inc. – Business Description
CorMedix, Inc. – Corporate Strategy
CorMedix, Inc. – SWOT Analysis
SWOT Analysis – Overview
CorMedix, Inc. – Strengths
CorMedix, Inc. – Weaknesses
CorMedix, Inc. – Opportunities
CorMedix, Inc. – Threats
CorMedix, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

CorMedix, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

CorMedix, Inc., Key Information
CorMedix, Inc., Key Ratios
CorMedix, Inc., Share Data
CorMedix, Inc., Major Products and Services
CorMedix, Inc., History
CorMedix, Inc., Key Employees
CorMedix, Inc., Key Employee Biographies
CorMedix, Inc., Key Operational Heads
CorMedix, Inc., Other Locations
CorMedix, Inc., Subsidiaries
CorMedix, Inc., Key Manufacturing facilities
CorMedix, Inc., Key Competitors
CorMedix, Inc., SWOT Analysis
CorMedix, Inc., Ratios based on current share price
CorMedix, Inc., Annual Ratios
CorMedix, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

CorMedix, Inc., Performance Chart
CorMedix, Inc., Ratio Charts

★海外企業調査レポート[CorMedix, Inc. (CRMD):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rhein Petroleum GmbH:企業のM&A・提携動向(石油・ガス分野)
    Summary Rhein Petroleum GmbH (Rhein Petroleum), a subsidiary of Tulip Oil Holding B.V., is an oil and gas company that explores and produces oil and natural gas. The company explores and produce crude oil in the southern German Oberrheingraben and in the Bavarian Alps. Its licensed areas of Oberrhei …
  • American Eagle Energy Corporation:企業のM&A・提携動向(石油・ガス分野)
    Summary American Eagle Energy Corporation (American Eagle Energy), formerly Eternal Energy Corp is an independent oil exploration company that acquires, explores, develops, and produces oil and gas properties in Canada and the US. The company acquires and develops Bakken wells in the Williston Basin …
  • Groupe Crit S.A. (CEN):企業財務及び戦略的SWOT分析
    Summary Groupe Crit S.A. (Crit) is a business and consumer service company that offers consulting services. The company provides staffing, engineering and maintenance services. It offers temporary staffing and recruitment, HR paperless, and training and consulting services. Crit also conducts resear …
  • 4iG Nyrt (4IG):企業の財務及び戦略的SWOT分析
    Summary 4iG Nyrt (4iG), formerly Freesoft Szoftverfejleszto & Szolg. Nyrt is an information technology company that provides software solutions. The company offers business intelligent solutions, software development and marketing and IT products and consulting programs. Its business intelligence so …
  • Neurotune AG(製薬・医療分野):企業M&A動向
    Summary Neurotune AG (Neurotune) is a biopharmaceutical company. The company develops medicationsand diagnostics for medical needs in neuromuscular and renal indications. Its products include NT-11624, NT-13317, NT-345 and ELISA. The company’s NT-11624 is in clinical phase 2 to treat osteoarthritis …
  • Ctrip.com International, Ltd.:企業のM&A・提携・投資分析
    Ctrip.com International, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ctrip.com International, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Concert Pharmaceuticals, Inc. (CNCE)(製薬・医療分野):企業M&A動向
    Summary Concert Pharmaceuticals, Inc. (Concert Pharmaceuticals) is a pharmaceutical company. The company creates novel medicines by applying our DCE Platform (Deuterated Chemical Entity Platform). Its products pipeline include CTP-354: used in the treatment of multiple sclerosis and spinal cord inju …
  • 4Energy Invest N.V. (ENINV):企業概要、財務及び戦略的SWOT分析
    Summary 4Energy Invest N.V. (4Energy Invest) is a renewable energy company. The company creates and manages small to middle-sized locally embedded biomass energy projects. It generates heat and electricity, and indirectly produce renewable solid fuels such as dried wood chips and white wood pellets. …
  • Navin Fluorine International Limited (NAVINFLUOR):企業財務及び戦略的SWOT分析
    Summary Navin Fluorine International Limited (NFIL) is a chemical company that manufactures and markets speciality fluorochemicals. The company offers refrigerants, inorganic fluorides, specialty fluorochemicals and others. Its refrigerants are used in various refrigeration and air conditioning appl …
  • Coca-Cola European Partners Plc:企業の戦略・SWOT・財務分析
    Coca-Cola European Partners Plc - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola European Partners Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Glu Mobile, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Glu Mobile, Inc. Mergers and Ac …
  • EFU Life Assurance Ltd. (EFUL):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "EFU Life Assurance Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly f …
  • PSA International Pte., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PSA International Pte., Ltd. Me …
  • Protea Biosciences Group Inc (PRGB):企業財務及び戦略的SWOT分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops technology for the identification, characterization, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic applications. The company’s products include prote …
  • Canadian Spirit Resources Inc. (SPI):企業のM&A・提携動向(石油・ガス分野)
    Summary Canadian Spirit Resources Inc. (CSRI) is a natural resource provider that offers exploration services. The company provides exploration and production of natural gas in Montney Formation of Northeast British Columbia. Its operation Farrell Creek area is located along the pipeline infrastruct …
  • Leap Therapeutics Inc (LPTX)-医療機器分野:企業M&A・提携分析
    Summary Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that acquires, develops novel therapeutics for cancer research. The company’s pipeline encompasses DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, and in clinical tria …
  • Biofilm S.A.:企業の戦略・SWOT・財務分析
    SummaryBiofilm S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Municipal Energy Agency of Nebraska:発電所・企業SWOT分析
    Municipal Energy Agency of Nebraska – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Advicenne SA:企業のM&A・提携動向(医療分野)
    Summary Advicenne SA (Advicenne) is a pharmaceutical company that focuses on development of innovative pediatric medicines. The company offers its products for the treatment of neurological diseases and renal disorders in children. Its products portfolio includes ADV6209, a liquid formulation of a b …
  • Seppic SA(製薬・医療分野):企業M&A動向
    Summary Seppic SA (Seppic) is a specialty ingredients manufacturer and supplier. It designs and supplies innovative specialty ingredients for the cosmetic, pharmaceutical, nutrition and vaccine markets. The company’s activities are segregated into personal care, human health, animal health and indus …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆